Abiopharma

New Form 8-K - Lantheus Holdings, Inc. Filed: 2025-07-22 AccNo: 0001193125-25-162233 Size: 162 KB Item 2.01: Completion of Acquisition or Disposition of Assets Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits